131 related articles for article (PubMed ID: 8095499)
21. Wild type p53 stimulates expression from the human multidrug resistance promoter in a p53-negative cell line.
Goldsmith ME; Gudas JM; Schneider E; Cowan KH
J Biol Chem; 1995 Jan; 270(4):1894-8. PubMed ID: 7829527
[TBL] [Abstract][Full Text] [Related]
22. Increased AP-1 activity in drug resistant human breast cancer MCF-7 cells.
Daschner PJ; Ciolino HP; Plouzek CA; Yeh GC
Breast Cancer Res Treat; 1999 Feb; 53(3):229-40. PubMed ID: 10369069
[TBL] [Abstract][Full Text] [Related]
23. Discrete mutations introduced in the predicted nucleotide-binding sites of the mdr1 gene abolish its ability to confer multidrug resistance.
Azzaria M; Schurr E; Gros P
Mol Cell Biol; 1989 Dec; 9(12):5289-97. PubMed ID: 2573836
[TBL] [Abstract][Full Text] [Related]
24. An E-box region within the prostaglandin endoperoxide synthase-2 (PGS-2) promoter is required for transcription in rat ovarian granulosa cells.
Morris JK; Richards JS
J Biol Chem; 1996 Jul; 271(28):16633-43. PubMed ID: 8663219
[TBL] [Abstract][Full Text] [Related]
25. Identification of the transcription factors NF-YA and NF-YB as factors A and B that bound to the promoter of the major histocompatibility complex class II gene I-A beta.
Celada A; McKercher SR; Maki RA
Biochem J; 1996 Aug; 317 ( Pt 3)(Pt 3):771-7. PubMed ID: 8760361
[TBL] [Abstract][Full Text] [Related]
26. An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene.
Choi KH; Chen CJ; Kriegler M; Roninson IB
Cell; 1988 May; 53(4):519-29. PubMed ID: 2897240
[TBL] [Abstract][Full Text] [Related]
27. Progesterone regulates the murine multidrug resistance mdr1b gene.
Piekarz RL; Cohen D; Horwitz SB
J Biol Chem; 1993 Apr; 268(11):7613-6. PubMed ID: 8096515
[TBL] [Abstract][Full Text] [Related]
28. Use of the human MDR1 promoter for heat-inducible expression of therapeutic genes.
Walther W; Stein U; Schlag PM
Int J Cancer; 2002 Mar; 98(2):291-6. PubMed ID: 11857422
[TBL] [Abstract][Full Text] [Related]
29. Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells.
Chin KV; Tanaka S; Darlington G; Pastan I; Gottesman MM
J Biol Chem; 1990 Jan; 265(1):221-6. PubMed ID: 1967174
[TBL] [Abstract][Full Text] [Related]
30. The human multidrug resistance 1 promoter has an element that responds to serum starvation.
Tanimura H; Kohno K; Sato S; Uchiumi T; Miyazaki M; Kobayashi M; Kuwano M
Biochem Biophys Res Commun; 1992 Mar; 183(2):917-24. PubMed ID: 1550597
[TBL] [Abstract][Full Text] [Related]
31. Quercetin, a bioflavonoid, inhibits the increase of human multidrug resistance gene (MDR1) expression caused by arsenite.
Kioka N; Hosokawa N; Komano T; Hirayoshi K; Nagata K; Ueda K
FEBS Lett; 1992 Apr; 301(3):307-9. PubMed ID: 1349537
[TBL] [Abstract][Full Text] [Related]
32. Structural and functional analysis of the mouse mdr1b gene promoter.
Cohen D; Piekarz RL; Hsu SI; DePinho RA; Carrasco N; Horwitz SB
J Biol Chem; 1991 Feb; 266(4):2239-44. PubMed ID: 1671222
[TBL] [Abstract][Full Text] [Related]
33. MDR1 gene expression: its effect on drug resistance to doxorubicin in human hepatocellular carcinoma cell lines.
Park JG; Lee SK; Hong IG; Kim HS; Lim KH; Choe KJ; Kim WH; Kim YI; Tsuruo T; Gottesman MM
J Natl Cancer Inst; 1994 May; 86(9):700-5. PubMed ID: 7908989
[TBL] [Abstract][Full Text] [Related]
34. Detection of multidrug resistance (MDR1) gene RNA expression in human tumors by a sensitive ribonuclease protection assay.
Ueda K; Yamano Y; Kioka N; Kakehi Y; Yoshida O; Gottesman MM; Pastan I; Komano T
Jpn J Cancer Res; 1989 Nov; 80(11):1127-32. PubMed ID: 2481665
[TBL] [Abstract][Full Text] [Related]
35. Transcriptional activation of human leukosialin (CD43) gene by Sp1 through binding to a GGGTGG motif.
Kudo S; Fukuda M
Eur J Biochem; 1994 Jul; 223(2):319-27. PubMed ID: 8055899
[TBL] [Abstract][Full Text] [Related]
36. Hyperthermia-induced nuclear translocation of transcription factor YB-1 leads to enhanced expression of multidrug resistance-related ABC transporters.
Stein U; Jürchott K; Walther W; Bergmann S; Schlag PM; Royer HD
J Biol Chem; 2001 Jul; 276(30):28562-9. PubMed ID: 11369762
[TBL] [Abstract][Full Text] [Related]
37. Characterization of the promoter regulatory region of the human pyruvate dehydrogenase beta gene.
Madhusudhan KT; Naik SS; Patel MS
Biochemistry; 1995 Jan; 34(4):1288-94. PubMed ID: 7827076
[TBL] [Abstract][Full Text] [Related]
38. Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdr1 gene activation by the cyclosporin PSC 833.
Beketic-Oreskovic L; Durán GE; Chen KG; Dumontet C; Sikic BI
J Natl Cancer Inst; 1995 Nov; 87(21):1593-602. PubMed ID: 7563202
[TBL] [Abstract][Full Text] [Related]
39. Differential over-expression of mdr1 genes in multidrug-resistant rat glioblastoma cell lines selected with doxorubicin or vincristine.
Schott B; Bennis S; Pourquier P; Ries C; Londos-Gagliardi D; Robert J
Int J Cancer; 1993 Aug; 55(1):115-21. PubMed ID: 8102127
[TBL] [Abstract][Full Text] [Related]
40. Two silencers regulate the tissue-specific expression of the collagen II gene.
Savagner P; Miyashita T; Yamada Y
J Biol Chem; 1990 Apr; 265(12):6669-74. PubMed ID: 2324096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
